Patents for C12P 21 - Preparation of peptides or proteins (112,499) |
---|
11/26/1992 | WO1992020793A1 CLONING AND RECOMBINANT PRODUCTION OF RECEPTOR(S) OF THE ACTIVIN/TGF-β SUPERFAMILY |
11/26/1992 | WO1992020792A1 Truncated forms of the hepatocyte growth factor (hgf) receptor |
11/26/1992 | WO1992020791A1 Methods for producing members of specific binding pairs |
11/26/1992 | WO1992020785A1 Tumor associated monoclonal antibody 81av78 |
11/26/1992 | WO1992020746A1 Polymeric compositions having bound antibodies |
11/26/1992 | WO1992020365A1 Therapeutic and diagnostic methods based on neurotrophin-4 expression |
11/26/1992 | WO1992020356A1 Tumor rejection antigen precursors, tumor rejection antigens and uses thereof |
11/26/1992 | WO1992020316A2 Targeted delivery of genes encoding immunogenic proteins |
11/26/1992 | DE4216355A1 Verfahren zur bereitstellung von antigen-spezifischen b- und t-lymphozyten sowie davon erhaltene monoklonale antikoerper A method of providing antigen-specific B- and T-lymphocytes obtained therefrom as well as monoclonal antibodies |
11/26/1992 | CA2109598A1 Therapeutic and diagnostic methods based on neurotrophin-4- expression |
11/26/1992 | CA2108767A1 Tumor associated monoclonal antibody 81av78 |
11/26/1992 | CA2108549A1 Plant defense gene(s) and regulatory element(s) |
11/26/1992 | CA2103376A1 Purification and cloning of p62 |
11/26/1992 | CA2103161A1 D-type cyclin and uses related thereto |
11/26/1992 | CA2103064A1 Targeted delivery of genes encoding immunogenic proteins |
11/26/1992 | CA2102704A1 Inhibitor of nf-kb transcriptional activator and uses thereof |
11/26/1992 | CA2087339A1 Dictyostelid expression vector and method for expressing a desired protein |
11/26/1992 | CA2086327A1 Cloning and recombinant production of receptor(s) of the activin/tgf- .beta. superfamily |
11/26/1992 | CA2083272A1 Novel antipathogenic peptides and compositions containing same |
11/25/1992 | EP0514488A1 Retinoid receptor compositions and methods |
11/25/1992 | EP0514481A1 Merosin, nucleic acids encoding, fragments and uses thereof |
11/25/1992 | EP0514413A1 Immunologically active peptides or polypeptides from the parvovirus b19. |
11/25/1992 | EP0514411A1 Polypeptides and dna encoding same, associated with human malaria parasites |
11/25/1992 | EP0348399B1 Sorbin and peptide derivatives which increase aborption by the mucous membranes |
11/25/1992 | EP0248084B1 Modulation of animal cellular responses with compositions containing isoxanthopterin-8-(1'-beta-aldoglycosidyl) derivatives |
11/25/1992 | EP0139676B1 Production and characterization of hybridoma antibodies directed specifically against common determinant(s) present among closely related, but distinct proteins |
11/25/1992 | CN1066470A Process for producing monocyte chemotactic factor polypeptide and train for production thereof |
11/25/1992 | CA2331239A1 Structure, production and use of heregulin |
11/24/1992 | US5166335 Heteropolysaccharide S-184 |
11/24/1992 | US5166323 Acid hydrolysis of gluten to improve solubility, absorption and emulsifiers |
11/24/1992 | US5166322 Cysteine added variants of interleukin-3 and chemical modifications thereof |
11/24/1992 | US5166321 Cecropin polypetides with activity against Gram-positive and Gram-negative bacteria |
11/24/1992 | US5166318 Anticoagulants |
11/24/1992 | US5166057 Templates for gene expression |
11/24/1992 | US5165922 Treatment of breast cancer |
11/24/1992 | US5165912 Reagents for diagnosis with antibodies reactive with enzymes |
11/24/1992 | CA2069199A1 Process for the clostripain-catalyzed linkage of arg-pro and arg-b (b=proteinogenous and non-proteinogenous amino acids) containing peptides |
11/24/1992 | CA1310601C Expression vectors |
11/21/1992 | CA2102292A1 The astrovirus human gastroenteritis agents and molecular cloning of corresponding cdnas |
11/19/1992 | EP0514207A2 Novel human neurokinin-1 receptor short form |
11/19/1992 | EP0513921A2 Recombinant vaccine against Marek's disease |
11/19/1992 | EP0513778A2 Hybrid monoclonal antibodies and compositions containing them |
11/19/1992 | EP0513738A2 Serum-free medium for mammalian cells cultivation |
11/19/1992 | EP0513565A1 Monoclonal antibodies against the plasmin-antiplasmin complex, process for their preparation and their use |
11/19/1992 | EP0513371A1 Human parainfluenza virus type 4a fusion protein and gene which codes for the same |
11/19/1992 | EP0513336A1 New variants derived from interferons of type i, production process thereof and their applications |
11/19/1992 | EP0513316A1 Analytical tracers for cancer, particularly malignant breast cancer. |
11/19/1992 | EP0513242A1 Lipopolysaccharide binding opsonin and methods of use thereof |
11/19/1992 | EP0513201A1 Leukocyte-derived growth factor |
11/19/1992 | EP0513090A1 Hepatitis a vaccines |
11/19/1992 | EP0513073A1 PROCESS FOR ENZYMATICAL CLEAVAGE OF RECOMBINANT PROTEINS BY MEANS OF IgA PROTEASES. |
11/19/1992 | EP0477290A4 Methods, compositions and devices for growing cells |
11/18/1992 | CN1066272A Process for preparation of anti-thrombin polypeptides |
11/18/1992 | CN1066193A Recursor form of boving growth hormone releasing factor and related dna compounds |
11/18/1992 | CN1019133B Monoclonal antibodies to pseudomonas aeruginosa flagella |
11/18/1992 | CA2068813A1 Hybrid monoclonal antibodies and compositions containing them |
11/18/1992 | CA2068372A1 Human neurokinin-1 receptor short form |
11/17/1992 | WO1992020783A1 Process for preparing antigen-specific b and t lymphocytes and monoclonal antibodies obtained therefrom |
11/17/1992 | US5164489 Protein growth factor useful in diagnosis and treatment of lung cancer |
11/17/1992 | US5164482 Recombinant aprotinin variants genetically engineered process for the microbial preparation of homogeneously processed aprotinin variants and the therapeutic use thereof |
11/17/1992 | US5164481 Peptides and analogues and mixtures thereof for detecting and eliciting antibodies to rubella virus |
11/17/1992 | US5164369 Asparagine, leucine, arginine, cysteine |
11/17/1992 | US5164366 Diabetes |
11/17/1992 | CA2087157A1 Process for preparing antigen-specific b and t lymphocytes and monoclonal antibodies obtained therefrom |
11/17/1992 | CA2068811A1 Protein from lactic acid bacteria |
11/17/1992 | CA2068764A1 Monoclonal antibodies against the plasmin-antiplasmin complex, a method for the preparation thereof and the use thereof |
11/17/1992 | CA1310286C Isolation of a gene encoding human thyrotropin beta subunit |
11/15/1992 | WO1992020373A1 Heteroconjugate antibodies for treatment of hiv infection |
11/15/1992 | CA2102511A1 Heteroconjugate antibodies for treatment of hiv infection |
11/12/1992 | WO1992019973A1 Novel antibodies, and methods for their use |
11/12/1992 | WO1992019969A1 Immunoassay for detecting group b streptococcus |
11/12/1992 | WO1992019759A1 Reconstituted human antibody against human interleukin 6 receptor |
11/12/1992 | WO1992019756A1 Monoclonal antibody specific for cathepsin l, hybridoma which produces the same, and method for using the same |
11/12/1992 | WO1992019755A1 MONOCLONAL ANTIBODY AGAINST HUMAN β2-GLYCOPROTEIN I AND USE THEREOF |
11/12/1992 | WO1992019750A1 Hybrid transposon with a pt-operon, plasmids and bacterial strains therefor |
11/12/1992 | WO1992019742A1 NOVEL HYBRID, SOLUBLE AND UNCLEAVED gp160 VARIANT |
11/12/1992 | WO1992019741A1 Hbv virus surface proteins with reduced host carbohydrate |
11/12/1992 | WO1992019740A1 Multiple hepatitis b virus surface proteins which form particles |
11/12/1992 | WO1992019737A1 Process for producing a monocyte chemotactic factor polypeptide and a strain for the production thereof |
11/12/1992 | WO1992019736A1 Growth hormone antagonists |
11/12/1992 | WO1992019735A1 GLYCAM-1 (Sgp 50), A SELECTIN LIGAND |
11/12/1992 | WO1992019734A1 Binding domains in notch and delta proteins |
11/12/1992 | WO1992019733A1 Thyroidal receptor for n-acetylglucosamine |
11/12/1992 | WO1992019650A1 Monoclonal antibodies specific for human thymidylate synthase |
11/12/1992 | WO1992019649A1 Antigens recognized by antibodies of rhumatoid polyarthritis, and preparation and use thereof |
11/12/1992 | WO1992019646A1 Analog of endothelial leukocyte adhesion molecule (elam) |
11/12/1992 | WO1992019634A1 Extended type 1 chain glycosphingolipids as tumor-associated antigens |
11/12/1992 | WO1992019269A1 Antibody recognizing endothelial cell ligand for leukocyte cr3 |
11/12/1992 | WO1992019268A1 New hepatitis a virus strain, method for the isolation of new hepatitis a virus strains and hepatitis a vaccines |
11/12/1992 | WO1992019106A1 Novel bacillus thuringiensis isolates for controlling acarides |
11/12/1992 | CA2109527A1 Amino-acid sequence homologies between selectins and b pertussis toxin-peptides derived therefrom, antibodies thereto and pharmaceutical compositions |
11/12/1992 | CA2109332A1 Antibody recognizing endothelial cell ligand for leukocyte cr3 |
11/12/1992 | CA2109090A1 Immunoassay for detecting group b streptococcus |
11/12/1992 | CA2109086A1 Monoclonal antibodies specific for human thymidylate synthase |
11/12/1992 | CA2108451A1 Novel antibodies, and methods for their use |
11/12/1992 | CA2108248A1 Novel bacillus thuringiensis isolates for controlling acarides |
11/12/1992 | CA2108029A1 Glycam-1(sgp 50), a selectin ligand |
11/12/1992 | CA2084876A1 Antigens specifically recognized by specific antibodies of rheumatoid arthritis, their constituent proteins, preparation and applications |
11/11/1992 | EP0512905A2 Heterobifunctional antibodies possessing both catalytic and specific antigen binding properties and methods using them |
11/11/1992 | EP0512733A2 Modified complement system regulator |